These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 14249422)

  • 1. PANEL DISCUSSION. 3. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. ASSAY OF ANTI-ANXIETY DRUGS BY QUANTITATIVE ELECTROENCEPHALOGRAPHY.
    PFEIFFER CC; GOLDSTEIN L
    J Neuropsychiatr; 1964 Oct; 5():475-86. PubMed ID: 14249422
    [No Abstract]   [Full Text] [Related]  

  • 2. TIME-SERIES, FREQUENCY ANALYSIS, AND ELECTROGENESIS OF THE EEGS OF NORMALS AND PSYCHOTICS BEFORE AND AFTER DRUGS.
    PFEIFFER CC; GOLDSTEIN L; MURPHREE HB; SUGERMAN AA
    Am J Psychiatry; 1965 Jun; 121():1147-55. PubMed ID: 14286047
    [No Abstract]   [Full Text] [Related]  

  • 3. THE ROLE OF TRANQUILIZERS IN MEDICAL PRACTICE IN THE CONTROL OF ANXIETY. IMPORTANT AND RELEVANT ASPECTS OF TRANQUILIZER THERAPY.
    RICKELS K
    J Neuropsychiatr; 1964 Oct; 5():442-7. PubMed ID: 14249415
    [No Abstract]   [Full Text] [Related]  

  • 4. THE PHARMACOLOGY OF TRANQUILIZING AGENTS.
    KRANTZ JC
    J Neuropsychiatr; 1964 Oct; 5():433-6. PubMed ID: 14249412
    [No Abstract]   [Full Text] [Related]  

  • 5. ELECTROENCEPHALOGRAPHIC ASSAY OF ANTI-ANXIETY DRUGS.
    PFEIFFER CC; GOLDSTEIN L; MURPHREE HB; JENNEY EH
    Arch Gen Psychiatry; 1964 May; 10():446-53. PubMed ID: 14128735
    [No Abstract]   [Full Text] [Related]  

  • 6. SYMPOSIUM ON ANXIETY AND A DECADE OF TRANQUILIZER THERAPY. THE TRANQUILIZER DECADE.
    BERGER FM
    J Neuropsychiatr; 1964 Oct; 5():403-10. PubMed ID: 14249406
    [No Abstract]   [Full Text] [Related]  

  • 7. CONDITIONED SUPPRESSION IN RATS AND THE EFFECT OF PHARMACOLOGICAL AGENTS THEREON.
    LAUENER H
    Psychopharmacologia; 1963 Jul; 4():311-25. PubMed ID: 14048553
    [No Abstract]   [Full Text] [Related]  

  • 8. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. THE NEED FOR A QUANTITATIVE APPROACH TO THE STUDY OF "DEPRESSANT TRANQUILIZERS".
    BEECHER HK; SMITH GM
    J Neuropsychiatr; 1964 Oct; 5():465-71. PubMed ID: 14249420
    [No Abstract]   [Full Text] [Related]  

  • 9. [THERAPEUTIC EFFECTS OF A HYPNOTIC COMPOUND WITH TRANQUILIZING PROPERTIES].
    CHARRIOT G; LAMBERT PA
    Lyon Med; 1964 Jun; 211():1557-67. PubMed ID: 14161670
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative EEG analysis of single-dose effect relationships in normal volunteers of Pacinox (capuride), a new antianxiety drug.
    Goldstein L; Pfeiffer CC
    Biol Psychiatry; 1971; 3(2):165-72. PubMed ID: 4932952
    [No Abstract]   [Full Text] [Related]  

  • 11. PLASMA FREE FATTY ACIDS IN RATS AFTER SHOCK AS MODIFIED BY CENTRALLY ACTIVE DRUGS.
    KHAN AU; FORNEY RB; HUGHES FW
    Arch Int Pharmacodyn Ther; 1964 Oct; 151():466-74. PubMed ID: 14228059
    [No Abstract]   [Full Text] [Related]  

  • 12. DOCTOR MEDICATION GUESSES: AN INDICATOR OF CLINICAL IMPROVEMENT IN DOUBLE-BLIND STUDIES. A CONTRIBUTION TO THE METHODOLOGY OF PSYCHIATRIC DRUG EVALUATION.
    RICKELS K; CARRANZA J; RAAB E
    J New Drugs; 1965; 5(2):67-71. PubMed ID: 14315152
    [No Abstract]   [Full Text] [Related]  

  • 13. CENTRAL NERVOUS SYSTEM DEPRESSANT ACTIVITY OF MA1337, 3-(3-(4-M-CHLOROPHENYL-1-PIPERAZYL)PROPYL)-2,4(1H,3H)QUINAZOLINEDIONE HYDROCHLORIDE.
    FUJIMORI H; COBB DP
    J Pharmacol Exp Ther; 1965 May; 148():151-7. PubMed ID: 14302151
    [No Abstract]   [Full Text] [Related]  

  • 14. [Driving tests to determine the influence of alcohol, tranquilizers and hypnotics on driing capability].
    Kielholz P; Goldberg L; Obersteg JI; Pöldinger W; Ramseyer A; Schmid P
    Dtsch Med Wochenschr; 1969 Feb; 94(7):301-6. PubMed ID: 5762987
    [No Abstract]   [Full Text] [Related]  

  • 15. Two double-blind, controlled studies comparing chlorethate, a new sedative-tranquilizer, with meprobamate and with phenobarbital.
    Beard WJ; Free SM
    J Clin Pharmacol J New Drugs; 1967; 7(1):41-5. PubMed ID: 4951239
    [No Abstract]   [Full Text] [Related]  

  • 16. DIAZEPAM, MEPROBAMATE, AND PLACEBO IN MUSCULOSKELETAL DISORDERS.
    PAYNE RW; SORENSON EJ; SMALLEY TK; BRANDT EN
    JAMA; 1964 Apr; 188():229-32. PubMed ID: 14113988
    [No Abstract]   [Full Text] [Related]  

  • 17. THE PLACE OF ACETYLSALICYLIC ACID IN PSYCHOPHARMACOLOGY. AN EXPERIMENTAL STUDY.
    FROMMEL E; FLEURY C; LEDEBUR IV; BEGUIN M; FAMILY S
    Arzneimittelforschung; 1963 Oct; 13():851-6. PubMed ID: 14196759
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECT OF TRANQUILIZERS ON THE METABOLISM OF ETHANOL.
    KHAN AU; FORNEY RB; HUGHES FW
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():171-6. PubMed ID: 14204491
    [No Abstract]   [Full Text] [Related]  

  • 19. PHARMACOLOGIC PROPERTIES OF A NEW TRANQUILIZING AGENT, 2-METHYL-2-PROPYLTRIMETHYLENE BUTYLCARBAMATE CARBAMATE (TYBAMATE).
    BERGER FM; KLETZKIN M; MARGOLIN S
    Med Exp Int J Exp Med; 1964; 10():327-44. PubMed ID: 14165722
    [No Abstract]   [Full Text] [Related]  

  • 20. MEPROBAMATE AND PHENOBARBITAL SODIUM IN ANXIOUS NEUROTIC PSYCHIATRIC AND MEDICAL CLINIC OUTPATIENTS. A CONTROLLED STUDY.
    RICKELS K; SNOW L
    Psychopharmacologia; 1964 Apr; 5():339-48. PubMed ID: 14151547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.